12 min listen
Episode 41: David Esposito - President and CEO at ONL Therapeutics
Episode 41: David Esposito - President and CEO at ONL Therapeutics
ratings:
Length:
20 minutes
Released:
Sep 19, 2023
Format:
Podcast episode
Description
What if your vision could be saved by the precise application of innovative biotech? Join us as we talk to David Esposito, President & CEO of ONL Therapeutics, and delve deep into his take on leadership. He shares how his military background has been instrumental in the successful management of clinical trials, particularly when navigating the unpredictable terrain of the COVID-19 pandemic. With their pipeline ONL1204, a FAS inhibitor targeting retinal disease, O&L Therapeutics is making significant strides in the ophthalmology space.First In Human is a biotech-focused podcast that interviews industry leaders and investors to learn about their journey to in-human clinical trials. Presented by Vial, a tech-enabled CRO, hosted by Simon Burns, CEO & Co-Founder. Episodes launch weekly on Tuesdays. To view the full transcript of this episode, click here.Interested in being featured as a guest on First In Human? Please reach out to catie@vial.com.
Released:
Sep 19, 2023
Format:
Podcast episode
Titles in the series (59)
Episode 4: Justin To - Chief Operating Officer at BridgeBio Pharma by First In Human By Vial